Abstract | OBJECTIVE: METHODS: Patients diagnosed with GCA from 1998 to 2013 with confirmed evidence of temporal artery biopsy and/or radiographic evidence of large vessel vasculitis were identified. Each patient with GCA treated with adjunct MTX (case) was matched to a similar patient with GCA treated only with GC (control). GC requirements and relapse events before and after MTX initiation (or corresponding index date) were compared using rate ratios (RR). RESULTS: Eighty-three cases and 83 controls were identified and compared. No significant differences in age, demographics, laboratory variables, baseline disease characteristics, or mean initial prednisone doses were observed. Median [interquartile range (IQR)] time from GCA diagnosis to MTX initiation in cases was 39 (13-80) weeks and the median (IQR) starting dose was 13.5 (10-15) mg/week. RR comparing relapse rates before and after MTX initiation/index date were significantly reduced in both cases (RR 0.32, 95% CI 0.24-0.41) and controls (RR 0.60, 95% CI 0.43-0.86). The decrease in relapse rate was significantly greater in patients taking MTX than in those taking GC alone (p = 0.004). Rates of GC discontinuation did not differ between groups. CONCLUSION: In this large single-institution cohort, the addition of MTX to GC decreased the rate of subsequent relapse by nearly 2-fold compared to patients taking GC alone. MTX may be considered as adjunct therapy in patients with GCA to decrease the risk of further relapse events.
|
Authors | Matthew J Koster, Karthik Yeruva, Cynthia S Crowson, Francesco Muratore, Cristian Labarca, Kenneth J Warrington |
Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 46
Issue 5
Pg. 501-508
(05 2019)
ISSN: 0315-162X [Print] Canada |
PMID | 30647171
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Academic Medical Centers
- Aged
- Biopsy, Needle
- Case-Control Studies
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Giant Cell Arteritis
(diagnostic imaging, drug therapy)
- Humans
- Male
- Methotrexate
(administration & dosage)
- Middle Aged
- North America
- Positron-Emission Tomography
(methods)
- Prednisone
(administration & dosage)
- Recurrence
- Retrospective Studies
- Risk Assessment
- Severity of Illness Index
- Treatment Outcome
|